WCN26-2643 ANTICOAGULATION THERAPY AND CLINICAL OUTCOMES IN PATIENTS UNDERGOING HEMODIALYSIS WITH ATRIAL FIBRILLATION: A TARGET TRIAL EMULATION

Read full text Summarise with VIRAT
Authors: Yoshihisa Miyamoto, Tomohiro Shinozaki, Akira Okada, Yusuke Sasabuchi, Hideo Yasunaga
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

While anticoagulation therapy is generally effective for stroke prevention in patients with atrial fibrillation (AF), its benefit in patients with kidney failure undergoing hemodialysis has not been clearly established, and concerns regarding increased bleeding complications persist. Previous studies may not have fully accounted for immortal time bias and competing risks. This study aimed to evaluate the association between anticoagulation therapy and clinical outcomes in hemodialysis patients with AF using a target trial emulation framework with the clone-censor-weight method.

Fields of Study & Subjects

Atrial Fibrillation Management and Outcomes Dialysis and Renal Disease Management Acute Ischemic Stroke Management

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104976–104976
Publication date
25 March 2026
Language
EN